Lundbeck
Bookmark
ShareCopied to clipboardLundbeck is a company. It is a public company in Princeton, the United States. It was founded in 1915 and its current CEO is Deborah Dunsire. It is part of the Health Care sector, specifically in the Pharmaceuticals industry.
Key facts
- city: Princeton
- country: United States
- employees: 5,353 people
- revenues: 2.2B $
- company type: public
- sector: Health Care
- industry: Pharmaceuticals
- foundation year: 1915
- CEO: Deborah Dunsire
- CEO approval: 81 %
- ESG score: Try Pro to see estimate
See more facts
Extract data
Download datasets about Lundbeck:
Dataset of stocks from Lundbeck:
Lundbeck is one of the companies in the United States, companies in Pharmaceuticals, companies in Health Care, companies in Princeton and 3,456,808 companies in our database.
Talking Points
- We are tirelessly dedicated to restoring brain health, so every person can be their best. Tweets from H. Lundbeck A/S. See privacy notice: https://t.co/YLvPLqZfTC
- We are tirelessly dedicated to restoring brain health, so every person can be their best. | Lundbeck is a global pharmaceutical company specialized in brain diseases. For more than 70 years, we have been at the forefront of neuroscience research and today our products are available in more than 100 countries. We are tirelessly dedicated to restoring ...
- H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia. It also provides Azilect for treating Parkinson's disease; Cipralex/Lexapro for depression; Ebixa to treat Alzheimer's disease; Onfi for Lennox-Gastaut syndrome; Sabril for treating epilepsy; and Xenazine for chorea associated with Huntington's disease, as well as other products. The company sells its products primarily to distributors of pharmaceuticals, pharmacies, and hospitals. It has a partnership agreement with Verantos to focus on a study to enable real-world evidence in support of migraine therapy; and collaboration with Rgenta Therapeutics, Inc. The company was founded in 1915 and is headquartered in Valby, Denmark.
- H. Lundbeck A/S is a wholesale company based out of Postboks 361, LYSAKER, Bærum, Norway. H. Lundbeck A/S H. Lundbeck A/S is a wholesale company based out of Postboks 361, LYSAKER, Bærum, Norway. LinkedIn. H. Lundbeck A/S Join ...
- Your development project with Lundbeck CDMO
- Lundbeck CDMO offers pharmaceutical subcontracting services for injectable and sterile forms, ranging from a small-scale test batch to the clinical lot to the commercial production of your medicines.
- We are tirelessly dedicated to restoring brain health, so every person can be their best. Tweets from H. Lundbeck a/s. See Privacy Notice: https://t.co/ylvplqzftc
- Laboratory Elaiapharm Lundbeck is a company based out of France.
- Research and development
- Our R&D activities are aimed at the discovery and development of new pharmaceuticals that target the underlying mechanisms of brain diseases.